Objective-Peroxisome proliferator-activated receptor ␥ (PPAR␥) is widely expressed in vessel walls, and it's activation by agonists showed beneficial effects in cardiovascular diseases. However, the role of endothelial cell (EC) PPAR␥ in atherogenesis is not fully understood. Methods and Results-To assess the contribution of endothelial-specific PPAR␥ in atherosclerosis, EC-specific PPAR␥ disruption and LDL receptor (LDLR) double-knockout (PPAR␥ ⌬EC /LDLR Ϫ/Ϫ ) mice were developed. When challenged with a high-cholesterol diet for 4 weeks, PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice exhibited severe atherosclerotic lesions compared to either their littermate controls or macrophage-specific PPAR␥ disruption and LDLR double knockout (PPAR␥ ⌬M⌽ / LDLR Ϫ/Ϫ ) mice. Metabolic analysis showed severe dyslipidemia and significant increase in systolic blood pressure in the PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice. Histological analysis and real-time quantitative PCR suggested an exacerbated inflammation in PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice, as revealed by the increases of proinflammatory gene expression and macrophage infiltration in vivo and in vitro. Furthermore, in vivo endothelial permeability was also increased by endothelial PPAR␥ disruption. Bone-marrow transplantation studies, which reconstituted hematopoietic PPAR␥, demonstrated that the accelerated atherogenesis was due to endothelial PPAR␥ deficiency.
P eroxisome proliferator-activated receptor ␥ (PPAR␥) is a ligand-activated nuclear transcription factor that has a central role in controlling adipocyte differentiation, lipid metabolism, and insulin sensitivity. 1 Clinically, PPAR␥ agonists, thiazolidinedione (TZD) class of drugs are used to improve insulin resistance and treat type 2 diabetes. PPAR␥ is also highly expressed in endothelial cells (ECs), macrophages (M), and smooth muscle cells, all of which are critical in atherosclerosis. Several studies have shown that TZD administration reduces atherosclerosis in both apolipoprotein E (apoE) Ϫ/Ϫ and low-density lipoprotein receptor (LDLR) Ϫ/Ϫ mice. [2] [3] [4] Recently, conditional disruption of PPAR␥ in macrophages demonstrated an increase in atherosclerosis under conditions of mild and severe hypercholesterolemia. 5 Moreover, disruption of PPAR␥ in smooth muscle cells augments angiotensin-II induced atherosclerosis in LDLR Ϫ/Ϫ mice 6 and exacerbates vascular lesion formation. 7 EC activation and dysfunction on exposure to atheroprone factors, such as oxidized lipids and proinflammatory stimuli, play a critical role in the initiation and progression of atherosclerosis. 8, 9 Increasing data have shown that PPAR␥ agonists inhibit inflammation in ECs and suppress the expression of vasoconstrictors endothelin-1 and angiotensin-II, but enhance the expression and activity of vasodilator nitric oxide in cultured ECs. 10 -14 Because PPAR␥ agonists demonstrate receptor-independent functions the direct role of PPAR␥ in ECs remains unknown. Moreover, in the PROACTIVE trial, the PPAR␥ agonist pioglitazone had beneficial effects on cardiovascular diseases, 15 but a recent meta-analysis demonstrates that the PPAR␥ agonist rosiglitazone was associated with an increase in risk of myocardial infarction and a trend toward a higher risk of cardiovascular death in patients with type 2 diabetes. 16 These clinical trials raise the importance of understanding the role of PPAR␥ in cell types critical in the progression of cardiovascular diseases.
In the present study, EC-specific PPAR␥ deficient mice were generated using the Cre/loxP system regulated by the Tie2 promoter on the LDLR Ϫ/Ϫ background. The data demonstrate that PPAR␥ deficiency in ECs significantly accelerates the initiation of atherosclerosis in LDLR Ϫ/Ϫ mice challenged with an atherogenic diet, demonstrating a protective role for endothelial PPAR␥ against the initiation and development of atherosclerosis.
Methods and Materials
Animals and Diets PPAR␥ F/F 17 , PPAR␥ ⌬EC 18, 19 and PPAR␥ ⌬M ⌽ 20 mice were previously described. LDLR Ϫ/Ϫ mice on a C57BL/6 background were purchased from Jackson Laboratories Inc (Bar Harbor, Me). PPAR␥ ⌬EC and PPAR␥ ⌬M ⌽ mice were crossed with LDLR Ϫ/Ϫ mice to obtain PPAR␥ ⌬EC /LDLR Ϫ/Ϫ and PPAR␥ ⌬M⌽ /LDLR Ϫ/Ϫ mice and the littermate PPAR␥ F/F /LDLR Ϫ/Ϫ were used as controls for all studies. All mice were maintained in microisolator cages with free access to rodent chow and water. Atherosclerosis was induced by feeding male mice an atherogenic rodent diet containing 1.25% cholesterol and 0.5% cholic acid (TD 02028, Harlan Teklad, Madison, WI) from 6 weeks old for the indicated times. All animal studies were carried out in accordance with Institute of Laboratory Animal Resources guidelines and approved by the National Cancer Institute Animal Care and Use Committee.
Serum Lipids and Lipoprotein Profiles
Mice were fasted overnight before blood sample collection. Total serum cholesterol and triglycerides were measured using kits from Wako (Wako Chemicals USA, Richmond, VA) according to the manufacturer's instructions. Lipoprotein profile was assessed by fast performance liquid chromatography using a Superose 6 column (Pharmacia, Piscataway, NJ) on a high-performance liquid chromatography system model 600 (Waters, Milford, MA). 21, 22 Blood Pressure Measurement Systolic blood pressure (BP) was analyzed by tail-cuff plethysmography on conscious (nonanesthetized) mice using BP-2000 BP analysis system (Visitech Systems, Apex, NC). All mice were trained on the apparatus for 1 week before the start of recording. Blood pressure was assessed in the morning and values were derived as an average of 10 independent measurements. One complete cycle was performed before recording to allow the mice to acclimate before the actual readings were taken.
Bone Marrow Transplantation
Six-week-old male PPAR␥ F/F /LDLR Ϫ/Ϫ and PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice were lethally irradiated with 9.5 Gy from a cesium gamma source 6 hours before transplantation. The 137 Cs source was in a Mark I Model 68 small animal irradiator (J. L. Shepherd & Associates, San Fernando, CA) operating at 2.57 Gy/min. This unit has a single 137 Cs source and provides uniform doses to small animals centered on the revolving turntable revolving at a constant rate of 4.75 revolutions per minute within the chamber. Bone marrow was collected from femurs of donor PPAR␥ F/F /LDLR Ϫ/Ϫ or PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice by flushing with sterile medium (RPMI 1640, 5 U/mL heparin, 50 U/mL penicillin, and 50 g/mL streptomycin). Each recipient mouse was injected with 5ϫ10 6 bone marrow cells through the tail vein. Four weeks after BMT, peripheral blood was collected for PCR analysis of bone marrow reconstitution. 23, 24 For atherosclerosis study, the mice were fed with high-cholesterol diet for another 4 weeks after confirming they were fully chimeric.
Analysis of Atherosclerotic Lesions
After 4 weeks of high-cholesterol diet, anesthetized mice were perfused with 10 mL of PBS via left ventricle, followed by 10 mL of 10% buffered formalin phosphate. After removal of the adventitia, the aorta was opened longitudinally, pinned flat onto a black-wax plate and stained with oil red O (Sigma) as previously described. 5 Plaques were analyzed under the Zeiss stemi 200-C microscope connected to an Olympus BX41 digital camera, and the lesions were quantified with Image J analysis software. To analyze atherosclerosis in the outflow tract and valve area of the heart, the top half of the heart was embedded in freezing media and stored at Ϫ80°C until sectioning. Serial 10-m-thick cryosections were cut and stained with hematoxylin and eosin as well as oil red O for quantifications of the lesion areas with the Image J analysis software. The aortic lesion size of each animal was obtained by the average in 6 sections from the same mice. 20
Isolation and Culture of Primary ECs
Primary ECs were isolated from the lungs of male PPAR␥ F/F / LDLR Ϫ/Ϫ or PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice. The mice were killed with carbon dioxide and the lungs were harvested and placed in DMEM. The tissues were trimmed, cut into small pieces, and incubated at 37°C with collagenase I (Invitrogen) for 45 minutes. The suspension was triturated with 30 cc syringe for 12 times, filtered through sterile 70-m disposable cell strainer (BD Biosciences, San Jose, CA), and centrifuged at 400 g for 8 minutes. The cell pellet was resuspended in Dulbecco's PBS and incubated with dynabeads (Invitrogen) coated with antimouse CD31 antibody (BD Biosciences) on a rotator for 10 minutes at room temperature. The cell-bound beads were washed 5 times with DMEM and cultured in Medium 200 (Invitrogen) with the addition of low-serum growth supplement (Invitrogen). Cells were grown in a collagen type I-coated plate and used at passage 2 for the experiments. The purification of ECs were Ͼ90% as confirmed by CD31 immunofluoresence staining.
Monocyte-EC Adhesion Assay
Monocytes were isolated from C57/B6 mice as previously described 20 and labeled with calcein-AM (invitrogen). Confluent ECs were treated with control or lipopolysaccharide for 16 hours and incubated with calcein-AM-labeled monocytes for 30 minutes. After 3 times washing with PBS monocytes bound to ECs were visualized on fluorescence microscopy. The number of bound monocytes was quantified by counting 5 microscopic fields per well in triplicates.
In Vivo Vascular Permeability Assay
Six-week-old male PPAR␥ F/F or PPAR␥ ⌬EC were injected with Evans blue dye (30 mg/kg in 100 L normal saline). Mustard oil diluted to 5% in corn oil or vehicle (corn oil) was applied to the dorsal and ventral surfaces of the ear and photographs were taken 15 minutes after dye injection. After mice were euthanized, ears were removed, dried, and weighed. Evans blue dye was extracted with 1 mL of formamide overnight at 55°C and measured spectrophotometrically at 620 nm. Values were expressed as g of dye/mg of ear tissue. 25
Immunohistochemistry
Snap-frozen fixed aortic rings embedded in OCT were sectioned, fixed in 10% buffered formalin phosphate and processed for antibody staining according to standard protocols. The following antibodies were used: anti-CD31 (BD Bioscience, San Jose, CA), F4/80 (Serotec, Raleigh, NC), VCAM-1 and ICAM-1 (R&D System, Minneapolis, MN). Positive cells and total cells were quantified from the aortic arch (5 different sections) from 4 different mice of each genotyping using IMAGE J software.
RNA Analysis
Total RNA was extracted from aortas, liver, or primary ECs using Trizol reagent (Invitrogen, Carlsbad, CA) and further purified by RNeasy columns (QIAGEN, Valencia, CA). Quantitative real-time PCR (qPCR) were performed using cDNA generated from 1 g total RNA with SuperScript II Reverse Transcriptase kit (Invitrogen). qPCR reactions were performed by use of SYBR green PCR master mix (Applied Biosystems, Foster City, CA) in an ABI Prism 7900HT sequence detection system (Applied Biosystems). Values were quantified by the comparative CT method and normalized to ␤-actin. Sequences for primers used to quantify mRNA are listed in Supplemental Table, available online at http://atvb.ahajournals.org.
Data Analysis
Results are expressed as meansϮSD. Statistical analysis was performed using the Student t test (2 groups) or one-way ANOVA with Bonferroni procedure for multiple comparison tests (Ն3 groups) with GraphPad Prism 5 (GraphPad Software Inc, San Diego, CA). Value of PϽ0.05 was considered statistically significant.
Results

Deletion of PPAR␥ by the Tie2-Driven Cre Recombinase Accelerates the Initiation of Atherosclerosis in LDLR ؊/؊ Mice
To investigate the contribution of EC PPAR␥ in the development of atherosclerosis, PPAR␥ ⌬EC /LDLR Ϫ/Ϫ were generated by crossing PPAR␥ ⌬EC 18, 19 with LDLR Ϫ/Ϫ mice. To verify tissue-specific PPAR␥ deficiency, genomic DNA recombination and mRNA levels were assessed in aorta, spleen, macrophage, liver, brown adipose tissue, and white adipose tissue (Supplemental Figure IA) . qPCR showed that Tie2-Cre directs an efficient PPAR␥ disruption in ECs and bone marrow-derived hematopoietic cells, but not in liver, brown adipose tissue, or white adipose tissue from Figure IB) . These results are consistent with previous data, in which Southern blot analysis revealed recombination in spleen and ECs. 18 Comprehensive analysis of atherosclerotic lesions was performed. Atherosclerotic plaques were not observed in PPAR␥ ⌬EC /LDLR ϩ/ϩ on high-cholesterol diet for 4 weeks (Supplemental Figure IIA Figure 1F ). Similarly, there was a significant increase of lipid-burden plaque area in PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice compared with their littermate controls as revealed by oil red O staining on cross-sectional aorta sinus ( Figure 1G ). These data demonstrate an accelerated atherogenesis in PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice, suggesting an important role for endothelial PPAR␥ in protecting against atherogenesis.
Deficiency of PPAR␥ in EC Accelerates the Initiation of Atherosclerosis in Ldlr ؊/؊ mice
Recent studies demonstrate that Tie2 is expressed in 20% of human blood monocytes. 26 To test whether a PPAR␥dependent mechanism in macrophages accounts for the ac-celerated atherogenesis in the PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice, mice with a conditional disruption of PPAR␥ in macrophages, were bred to the LDLR Ϫ/Ϫ background (PPAR␥ ⌬M / LDLR Ϫ/Ϫ ). Interestingly, as revealed by en face staining with aorta ( Figure 2A ), PPAR␥ ⌬M /LDLR Ϫ/Ϫ mice on 4 weeks of high-cholesterol diet did not develop an increase in atherosclerotic lesions compared to PPAR␥ F/F /LDLR Ϫ/Ϫ littermate control mice. Although a previous study showed that macrophage-specific PPAR␥ deficiency could increase atherosclerosis in LDLR Ϫ/Ϫ mice challenged with 16 weeks of butterfat diet, 5 our data suggested that disruption of PPAR␥ in macrophage might not be essential for the initiation of atherogenesis.
PPAR␥ is disrupted in bone-marrow-derived hematopoietic cells by the Tie2-driven Cre recombinase. 18, 19 To further elucidate whether the large increase in atherogenesis in PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice was due to decreased PPAR␥ in hematopoietic cells, bone marrow transplantation was undertaken. Bone marrow from PPAR␥ F/F /LDLR Ϫ/Ϫ or PPAR␥ ⌬EC /LDLR Ϫ/Ϫ was transplanted into 6-week-old, lethally irradiated PPAR␥ ⌬EC /LDLR Ϫ/Ϫ or PPAR␥ F/F / LDLR Ϫ/Ϫ mice, respectively. Four weeks after transplantation, peripheral blood was collected confirming full reconstitution of donor hematopoietic cells in the recipient mice. (Figure 2B ). Mice were fed high-cholesterol diet for 4 weeks following bone marrow transplantation. PPAR␥ F/F / LDLR Ϫ/Ϫ mice reconstituted with PPAR␥ ⌬EC /LDLR Ϫ/Ϫ bone marrow exhibited 3.4%Ϯ0.26% of lesion areas in aortic arch ( Figure 2C Figure 2D , 0.079Ϯ0.004 mm 2 ). These data suggest that loss of PPAR␥ in bone-marrow-derived hematopoietic cells could not account for the enhanced aortic atherosclerosis in PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice. These data indicate that EC dysfunction in host mice lacking PPAR␥ is likely a major cause of lesion initiation in PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice.
Deficiency of PPAR␥ in EC Increases Serum Cholesterol and Triglycerides Following High-cholesterol Diet
Multiple metabolic parameters were assessed following highcholesterol diet administration. No changes in body weights were observed between PPAR␥ ⌬EC /LDLR Ϫ/Ϫ and littermate control mice on standard chow or high-cholesterol diet ( Figure 3A) . At 1 week of high cholesterol feeding, both genotypes developed dyslipidemia ( Figure 3B ). PPAR␥ ⌬EC / LDLR Ϫ/Ϫ mice manifested more marked accumulation of serum cholesterol ( Figure 3C , 2880Ϯ572 versus 1420Ϯ139 mg/dL) and TG ( Figure 3D , 1170Ϯ209 versus 732Ϯ171 mg/dL) than PPAR␥ F/F /LDLR Ϫ/Ϫ controls. Cholesterol concentrations were also measured in lipoprotein fractions separated by fast protein liquid chromatography. PPAR␥ ⌬EC / LDLR Ϫ/Ϫ mice exhibited more VLDL and LDL than PPAR␥ F/F /LDLR Ϫ/Ϫ mice ( Figure 3E ). Previous studies indicated that PPAR␥ in the endothelium regulates the metabolic response to high-fat diet in mice. 18, 19 In primary ECs isolated from PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice, a series of known PPAR␥ target genes involved in cholesterol and triglyceride metabolism were analyzed. No changes were found in mRNA expression of ABCA1 and ABCG1, which are known as cholesterol reverse transporters. However, CD36, a longchain fatty acid receptor that facilitates fatty acid uptake, was significant decreased in ECs from PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice. Fatty acid binding protein 4 was also repressed in the PPAR␥-deficient ECs ( Figure 3F ).
EC PPAR␥ Disruption Is Associated With Increased Blood Pressure After High-Cholesterol Diet Feeding
Because hypertension is a major risk factor for atherosclerosis, systolic BP was analyzed using tail-cuff plethysmography. Without high-cholesterol diet challenge, there was no significant difference between PPAR␥ ⌬EC /LDLR Ϫ/Ϫ (124Ϯ 6.2 mm Hg) and PPAR␥ F/F /LDLR Ϫ/Ϫ (120Ϯ3.4 mm Hg). High-cholesterol diet feeding increased systolic BP in both groups, however, PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice showed a higher mean systolic BP compared with their littermate controls (Table) . This is consistent with previous data showing that PPAR␥ deficiency in EC does not influence basal BP but augments high-fat diet-induced hypertension. 18 Measurement of AngII type 1 receptor (AT 1 R) and eNOS mRNAs in the aortas from mice on standard chow diet or high-cholesterol diet revealed no statistical difference in levels between PPAR␥ F/F /LDLR Ϫ/Ϫ and PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice on standard chow diet. When challenged with a high-cholesterol diet, an increase of AT 1 R mRNA was detected in PPAR␥ ⌬EC / LDLR Ϫ/Ϫ mice compared to their littermate controls. However, no changes of eNOS mRNA was detected between these 2 groups (Supplemental Figure III) .
Disruption of EC PPAR␥ Increases Endothelial Permeability
It was hypothesized that the dysfunction of ECs is an important early event for the development of atherosclerosis 8, 9 and the sites of plaque development may be associated with impaired EC functions. To determine the potential mechanisms of enhanced atherosclerosis in the PPAR␥ ⌬EC / LDLR Ϫ/Ϫ mice, endothelial barrier function in the mice was assessed. Leakage of Evans Blue dye into interstitial tissues of the mouse ear after treatment with mustard oil directly correlates to impaired endothelial barrier function. PPAR␥ ⌬EC mice exhibited a significantly higher degree of vascular leakage when compared to PPAR␥ F/F mice ( Figure  4A and B, 46.8Ϯ9.09 g/mg in PPAR␥ F/F versus 89.5Ϯ17.4 in PPAR␥ ⌬EC , PϽ0.05), indicating an impaired endothelial function after PPAR␥ deficiency. To elucidate the mechanisms of increased endothelial permeability by EC-PPAR␥ disruption, genes involved in adherens junctions and tight junctions were evaluated. No significant change was found in the mRNA levels of VE-cadherin, claudins, zonula occludens, or occludins ( Figure 4C ).
Increased Inflammation and Macrophage Infiltration by PPAR␥ Disruption In Vitro and In Vivo
A significant increase in endothelial permeability was observed after disruption of PPAR␥ in EC. Because no direct transcriptionally mediators were identified, inflammation was assessed. Proinflammatory mediators were shown to be direct repressive targets of PPAR␥ 27, 28 and increased inflammation is a major mechanism leading to endothelial barrier dysfunction. 28, 29 To understand the mechanism by which ECs are activated, primary ECs were used and the expression patterns of proinflammatory genes were analyzed. PPAR␥-deficient ECs exhibited higher expression of inflammatory chemokines and adherent molecules, such as MCP-1, ICAM-1, and VCAM-1, which are important for monocyte recruitment and interaction with endothelium. Interestingly, iNOS, a key mediator critical for inflammation and barrier permeability, was dramatically increased after EC-PPAR␥ disruption. Moreover, the expression of the above genes was further extended in response to lipopolysaccharide treatment for 16 hours ( Figure 5A ). Next, EC-monocyte adhesion assays were performed to determine the recruitment of monocytes to activated ECs. PPAR␥ disruption markedly increased the primary monocyte adhesion to ECs under basal level, and preadministration of lipopolysaccharide augmented the recruitment and adhesion of monocytes to ECs ( Figure 5B) . These data demonstrated an activated phenotype of ECs by PPAR␥ loss-of-function in ECs in vitro. Activation of ECs was further assessed by analysis of mRNAs encoding inflammatory modulators in the vessel wall of PPAR␥ ⌬EC / LDLR Ϫ/Ϫ mice after high-cholesterol diet treatment. Consistent with in vitro data, several inflammatory molecules, MCP-1, iNOS, and TNF␣, were significantly upregulated in the PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice compared to PPAR␥ F/F / LDLR Ϫ/Ϫ . VCAM-1, which is expressed after the activation of ECs and mediates the adhesion of leukocytes, was also significantly increased in PPAR␥ ⌬EC /LDLR Ϫ/Ϫ aorta ( Figure  5C ). In addition, the expression of VCAM-1 and macrophage marker F4/80 was examined in aortic roots by immunofluorescent staining. PPAR␥ ⌬EC /LDLR Ϫ/Ϫ mice demonstrated a greater area positive for VCAM-1 and F4/80 ( Figure 5D ), indicating an exacerbated macrophage infiltration and inflammation after PPAR␥ disruption in ECs.
Discussion
Atherosclerosis is a complex disease due to the formation of atherosclerotic lesions consisting of accumulated modified lipids, VSMCs, ECs, leukocytes, and foam cells. 30, 31 PPAR␥ is highly expressed in both the normal vasculature, including ECs, VSMCs, and macrophages, 17, 32, 33 and in atherosclerotic plaques. 34 Several studies were performed to investigate the role of PPAR␥ in the development of atherosclerosis. In macrophage, loss of PPAR␥ leads to reduced cholesterol efflux and decreased expression of lipoprotein lipase, liver X receptor, and ABCG1. 17 Transplantation of PPAR␥-deficient macrophage 5, 35 into LDLR Ϫ/Ϫ mice resulted in significant increase of atherosclerotic lesions. Others showed that PPAR␥ deficiency in VSMC specifically could augment angtension II-induced atherosclerosis without affecting abdominal aortic aneurysms. 6 Although these studies demonstrated a beneficial effect of PPAR␥ in more advanced stages of atherosclerotic lesions, little is known about the role of PPAR␥ in the initiation of atherosclerosis.
The present study demonstrated that PPAR␥ in ECs is a critical player in protecting against the development of atherosclerosis, especially the initiation of atherogenesis using a loss-of-function strategy. LDLR Ϫ/Ϫ mice with ECspecific disruption of PPAR␥ develop atherosclerosis as early as 4 weeks on a high-cholesterol diet, suggesting an important vascular protective role of endothelial PPAR␥ against atherogenesis. Mechanistically, disruption of EC PPAR␥ leads to an increase of several proatherosclerotic pathways including exacerbated dyslipidemia, raised systolic BP, increased endothelial permeability, enhanced expression of proinflammatory cytokines, and increased monocyte/macrophage recruitment and infiltration into vessel walls.
ECs serve as an important barrier between vascular tissue and blood components as well as modulate the traffic of immune cells. Its activation on exposure to cardiovascular risk factors, such as hyperglycemia, hypercholesterolemia, hypertension, and smoking is the first step of atherogenesis. 36 Disruption of PPAR␥ in ECs exacerbates dyslipidemia in LDLR Ϫ/Ϫ mice. Defective cholesterol and triglyceride metabolism in EC after PPAR␥ disruption might contribute to the large increases in serum lipid concentrations. A previous study showed PPAR␥ in ECs regulates metabolic responses to high-fat diet in mice, in which defective fatty acid uptake and triglyceride metabolism occurred only in the absence of EC PPAR␥. 19 The data in the present article further confirms the role of EC PPAR␥ in regulation of lipid homeostasis.
Hypertension is a major risk factor for atherosclerosis and cardiovascular disease. The current study showed that PPAR␥ disruption in EC raised systolic BP after a highcholesterol diet challenge. In addition, AT1R mRNA was also significantly upregulated, suggesting an impaired vascular activity. Others revealed that PPAR␥ disruption in EC is associated with impaired vascular relaxation after a high-fat diet in which carotid artery dilation response to carbachol was measured after phenylephrine preconstriction. 19 In addition, an increased contraction in aortic rings was demonstrated in PPAR␥ KO mice. 37 These data support the current study of endothelial dysfunction and increased BP in PPAR␥ ⌬EC mice.
Deficiency of EC PPAR␥ dramatically upregulated several proinflammtory molecules, such as vascular adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1), and TNF␣ in the vessel wall, all of which are critical for the recruitment, rolling, and trafficking of monocytes into subendothelium. This result is consistent with in vitro studies showing that PPAR␥ activation by its ligands inhibits proinflammatory cytokines and chemokines in ECs. 12, 38, 39 Recent, bioinformatics analysis of gene sets regulated by ligand-ac- tivated and dominant-negative PPAR␥ in the mouse aorta is consistent with the present study. VCAM-1, ICAM-1, MCP-1, and TNF␣ mRNA expression were repressed by PPAR␥ ligand rosiglitazone and induced by PPAR␥ P465L dominant-negative mutation. 40 Disruption of PPAR␥ in EC significantly raised vascular permeability as demonstrated by Evans Blue leakage assay. Although no transcriptional changes of barrier genes were observed, dyslipidemia and increased inflammation that are found in the result in impaired barrier function of ECs. Inflammation and iNOS can increase barrier permeability in EC. 41 This is consistent with the present results showing increased proinflammatory cytokines, chemokines, and iNOS in PPAR␥ ⌬EC mouse ECs that have elevated vascular permeability.
The present study demonstrates PPAR␥ deficiency in EC leads to multiple endothelial dysfunctions in LDLR Ϫ/Ϫ mice exposed to high-cholesterol diet. Although further study is needed to explore which is the first step in this process, the current study provides first definitive evidence that endothelial PPAR␥ serves as a critical player for protecting against the initiation of atherosclerosis using EC-specific PPAR␥ disruption animal models and thus raises a potentially clinical therapeutic strategy to prevent atherogenesis. 
